If the unveiling and the efficacy of brand Lumal, from the production line ofÂ SKG- Pharma is anything to go by, then, the brand will become the toast of malaria patients.
Experts in the field of medicine had confirmed in an exclusive interview that the war against malaria is half won if and when the number of people who are ready to tango with Lumal to fight the malaria scourge.
In as much, clinicians and stakeholders in the medical field tend to follow the current trend in the treatment of malaria, as well as making the disease a major health concern in Nigeria, then.
Dr. Chinwe Nwokolo, in a lecture entitled; â€œCurrent Trend in Malaria Treatment,â€ stated the need for Nigerian clinicians to contribute their quotas in the global malaria control, while stressing that the incidences of malaria in Nigeria presently pushed the company to come out with the Lumal solution.
Nwokolo who regretted that in spite of the huge amount of money spent by the country on malaria, worried that malaria not attack the health of an individual but comes with social, economic and health problems.
Lamenting that only 30 per cent of children under 5 receive malaria treatment in Nigeria, she called for formulation of appropriate policy and availability of drugs as prerequisites for improving case management of malaria.
Continuing, Nwokolo who was the guest lecturer at the launch of Lumal , said in home management of malaria, there should be rapid recognition of malaria and need for minimal efficacy of 90 per cent product on malaria treatment amongst others.
She identified seven challenges to malaria treatment as provider perception, use of oral Artemethre, monotherapies, patience compliance, improve diagnostics, cost of treatment, drug efficacy monitoring and reporting amongst others.
Commenting on Lumal, she stressed the need for more efficacious malaria drug in the country with a view to eliminating malaria in Nigeria. Apparently, endorsing the drug, she said it is very effective in the treatment of malaria in infants, children and adults because of itâ€™s combination of Artemether and Lumetantrine.
Earlier, the Managing Director of SKG-Pharma, Mr. Okechukwu Agba, who recalled that the company has produced not less than 12 products in the country since last year pledged the companyâ€™s commitment to providing affordable and quality drugs for Nigerians.
Giving it message for the year as â€œTogether we will winâ€ at the formal at the ceremony to also recognise performance as well as reward deserving customers and staff, he promised to do better and partner with the Nigerian governments at all levels.
Unveiling the product, the wife of the Lagos State Governor, Mrs. Abimbola Fashola. expressed hope that the drug would help in the efforts of the country towards eradicating malaria.
Mrs. Ololade Alade, who represented the Director-General of the National Agency for Food, Drugs Administration and Control, NAFDAC, commended SKG-Pharma for its consistency in the provision of quality products and encouraged the company not to rest on its oars.
The Trade Brand Manager of SKG Pharma, Ms Rachael Ogo explained that Lumal is a fixed dose combination of two anti malaria agents and encourages patients compliance as well as reliable in the treatment of malaria.